PRECISION: PERSONALISED RISK EVALUATION IN DCIS, INTERNATIONAL

Abstract

Ductal carcinoma in situ (DCIS) of the breast is a common diagnosis with problematic clinical management. This study brings together an international consortium to identify and validate clinical biomarkers of recurrence.